Surfactant Administration Through Laryngeal or Supraglottic Airways

Area of Science:

• Neonatal Medicine
• Pulmonology
• Medical Devices

Background:

• Noninvasive ventilation (NIV) is common for infant respiratory distress syndrome (RDS).
• NIV success is limited in preterm infants due to severe surfactant deficiency and lung non-compliance.
• Intubation carries risks, prompting development of less invasive surfactant delivery methods.

Purpose of the Study:

• To review minimally invasive surfactant administration (MISA) techniques.
• To focus on surfactant delivery via laryngeal mask airway (LMA) or supraglottic airway (SGA).
• To provide a procedural guide for LMA/SGA surfactant administration.

Main Methods:

• Review of historical data, animal studies, and human trials on MISA.
• Comparison of LMA/SGA surfactant delivery with other MISA techniques.
• Development of a step-by-step instructional guide with multimedia support.

Main Results:

• Several MISA methods exist, including thin catheter, aerosolization, and LMA/SGA.
• LMA/SGA offers a potential alternative to endotracheal intubation for surfactant delivery.
• Current FDA-approved surfactant delivery is via endotracheal tube; other methods are off-label.

Conclusions:

• Minimally invasive surfactant administration, especially via LMA/SGA, may enhance NIV success in preterm infants.
• Further research and clinical adoption of off-label MISA techniques are warranted.
• Procedural guidance is crucial for safe and effective LMA/SGA surfactant administration.